CPA
AUGX

Cowen Prime Advisors’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Cowen Prime Advisors’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$6.45M Sell
1,341,000
-97,500
-7% -$337K 2.22% 11
2023
Q1 		$4.33M Buy
1,438,500
+696,400
+94% +$1.14M 1.73% 14
2022
Q4 		$1.16M Buy
+742,100
New +$945K 0.48% 43

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Cowen Prime Advisors's AUGX Position: Q2 2023 in Review

Cowen Prime Advisors reduced its Augmedix, Inc. Common Stock (AUGX) stake by 6.8% in Q2 2023, selling an estimated $337K and leaving 1,341,000 shares worth $6.45M. The position accounts for 2.22% of the portfolio, ranked #11.

Cowen Prime Advisors first reported a position in AUGX in Q4 2022 and has held it in 3 quarters since. 50 funds tracked by Wall St. Rank hold AUGX as of Q2 2023.

  • Cowen Prime Advisors held 1,341,000 shares of Augmedix, Inc. Common Stock worth $6.45M as of Q2 2023.
  • Cowen Prime Advisors sold 97,500 Augmedix, Inc. Common Stock shares in Q2 2023, an estimated $337K.
  • Augmedix, Inc. Common Stock made up 2.22% of Cowen Prime Advisors's portfolio in Q2 2023, its #11 holding.
  • Cowen Prime Advisors first reported a position in Augmedix, Inc. Common Stock in Q4 2022 and has held it in 3 quarters since.
  • 50 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.